Novo Holdings sells 327,919 Lexeo shares, retains $148.13m in Edgewise and $3.52m in IO Biotech.

Novo Holdings A S has recently sold 327,919 shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO). Additionally, the firm holds $148.13 million in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) and has a $3.52 million position in IO Biotech, Inc. (NASDAQ:IOBT).

October 27, 2024
3 Articles

Further Reading